268 related articles for article (PubMed ID: 16154648)
1. Intraventricular injections of tachykinin NK3 receptor agonists suppress the intake of "salty" tastes by sodium deficient rats.
Flynn FW
Behav Brain Res; 2006 Jan; 166(1):1-8. PubMed ID: 16154648
[TBL] [Abstract][Full Text] [Related]
2. Intraventricular injection of tachykinin NK3 receptor agonists suppresses the ingestion of NaCl-associated tastes.
Flynn FW
Behav Neurosci; 2000 Dec; 114(6):1223-8. PubMed ID: 11142654
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of intraventricular injections of tachykinin NK1 and NK3 receptor agonists on normal and sham drinking of NaCl by sodium-deficient rats.
Flynn FW; Smith ME; Bieber SL
Behav Neurosci; 1999 Aug; 113(4):776-86. PubMed ID: 10495085
[TBL] [Abstract][Full Text] [Related]
4. Lateral ventricular injections of the NK3 agonist senktide affect salt taste-elicited responses.
Flynn FW; Smith ME
Peptides; 1998; 19(2):319-24. PubMed ID: 9493864
[TBL] [Abstract][Full Text] [Related]
5. Effects of the selective tachykinin NK3 receptor agonist NH2-senktide on intraoral intake and taste reactivity responses elicited by NaCl in sodium-replete rats.
Polidori C; Pompei P; Ciccocioppo R; de Caro G; Massi M
Regul Pept; 1996 Oct; 66(1-2):101-4. PubMed ID: 8899901
[TBL] [Abstract][Full Text] [Related]
6. Intraventricular injections of tachykinin NK3 receptor agonist reduce the gain of the baroreflex in unrestrained rats.
Flynn FW
Exp Neurol; 2005 May; 193(1):118-24. PubMed ID: 15817270
[TBL] [Abstract][Full Text] [Related]
7. Central injection of senktide, an NK3 receptor agonist, or neuropeptide Y inhibits LH secretion and induces different patterns of Fos expression in the rat hypothalamus.
Sandoval-Guzmán T; Rance NE
Brain Res; 2004 Nov; 1026(2):307-12. PubMed ID: 15488494
[TBL] [Abstract][Full Text] [Related]
8. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
Nordquist RE; Durkin S; Jacquet A; Spooren W
Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
[TBL] [Abstract][Full Text] [Related]
9. Tachykinin NK3 receptor agonist blocks sodium deficiency-induced shift in taste reactivity.
Smith ME; Flynn FW
Brain Res; 1994 Nov; 665(1):123-6. PubMed ID: 7533632
[TBL] [Abstract][Full Text] [Related]
10. Interaction of the tachykinin NK3 receptor agonist senktide with behavioral effects of cocaine in marmosets (Callithrix penicillata).
de Souza Silva MA; Mello EL; Müller CP; Jocham G; Maior RS; Huston JP; Tomaz C; Barros M
Peptides; 2006 Sep; 27(9):2214-23. PubMed ID: 16621146
[TBL] [Abstract][Full Text] [Related]
11. GABA(A) receptor activation in the lateral parabrachial nucleus induces water and hypertonic NaCl intake.
Callera JC; Oliveira LB; Barbosa SP; Colombari DS; De Luca LA; Menani JV
Neuroscience; 2005; 134(3):725-35. PubMed ID: 16009500
[TBL] [Abstract][Full Text] [Related]
12. Baclofen into the lateral parabrachial nucleus induces hypertonic sodium chloride and sucrose intake in rats.
De Oliveira LB; Kimura EH; Callera JC; De Luca LA; Colombari DS; Menani JV
Neuroscience; 2011 Jun; 183():160-70. PubMed ID: 21419196
[TBL] [Abstract][Full Text] [Related]
13. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
14. Intraventricular injections of tachykinin NK3 receptor agonists affect salt intake. A shift in taste intensity?
Smith ME; Flynn FW
Ann N Y Acad Sci; 1999; 897():432-5. PubMed ID: 10676471
[No Abstract] [Full Text] [Related]
15. Selective agonists at NK3 tachykinin receptors inhibit alcohol intake in Sardinian alcohol-preferring rats.
Ciccocioppo R; Panocka I; Pompei P; De Caro G; Massi M
Brain Res Bull; 1994; 33(1):71-7. PubMed ID: 7506113
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
17. The NK3 receptor agonist senktide ameliorates scopolamine-induced deficits in memory for object, place and temporal order.
Schäble S; Huston JP; Barros M; Tomaz C; de Souza Silva MA
Neurobiol Learn Mem; 2012 Feb; 97(2):235-40. PubMed ID: 22209911
[TBL] [Abstract][Full Text] [Related]
18. Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine.
Bealer SL; Flynn FW
Exp Neurol; 2003 Dec; 184(2):1027-33. PubMed ID: 14769397
[TBL] [Abstract][Full Text] [Related]
19. Activation of the cloned human NK3 receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer.
Jordan RE; Smart D; Grimson P; Suman-Chauhan N; McKnight AT
Br J Pharmacol; 1998 Oct; 125(4):761-6. PubMed ID: 9831912
[TBL] [Abstract][Full Text] [Related]
20. Brain tachykinins and the regulation of salt intake.
Flynn FW
Ann N Y Acad Sci; 1999; 897():173-81. PubMed ID: 10676446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
